ARTICLE | Clinical News
Interferon Alpha-2b: IND hold
December 6, 2010 8:00 AM UTC
FDA placed a clinical hold on an IND for a planned Phase II/III trial of Interferon Alpha 2b to treat CIN grade 1 or 2 lesions. Helix said the agency requested additional stability data, which the com...